Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.12
+0.04 (0.79%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Lifecore Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | 2021 - 2017 |
| Net Income | -30.79 | -38.72 | 12.01 | -99.56 | -116.72 | Upgrade
|
| Depreciation & Amortization | 9.5 | 8.03 | 7.95 | 12.68 | 17.66 | Upgrade
|
| Other Amortization | - | - | - | 0.5 | 0.4 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 7.78 | 0.02 | -2.07 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.64 | 5.19 | Upgrade
|
| Stock-Based Compensation | 9.72 | 10.16 | 6.2 | 3.61 | 2.61 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.16 | -0.01 | Upgrade
|
| Other Operating Activities | 29.45 | 17.25 | -22.23 | 24.53 | -7.25 | Upgrade
|
| Change in Accounts Receivable | 2.76 | -5.17 | -2.39 | 10.82 | -6.14 | Upgrade
|
| Change in Inventory | 5.5 | 7.69 | 0.86 | -14.81 | -2.18 | Upgrade
|
| Change in Accounts Payable | -2.98 | -1.67 | -6.68 | 16.04 | 9.34 | Upgrade
|
| Change in Unearned Revenue | - | - | - | 6.08 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | -10.59 | -5.54 | 4.51 | 1.66 | -4.11 | Upgrade
|
| Operating Cash Flow | 12.57 | -0.21 | 0.26 | -17.44 | -22.59 | Upgrade
|
| Capital Expenditures | -6.34 | -13.42 | -18.4 | -21.48 | -29.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 17.14 | 7 | - | - | 1.14 | Upgrade
|
| Divestitures | - | - | - | 16.67 | 73.5 | Upgrade
|
| Other Investing Activities | - | - | - | - | 35.26 | Upgrade
|
| Investing Cash Flow | 10.81 | -6.42 | -18.4 | -4.81 | 79.96 | Upgrade
|
| Long-Term Debt Issued | - | 128.57 | 149.59 | 181.45 | 75.11 | Upgrade
|
| Total Debt Issued | 104.79 | 128.57 | 149.59 | 181.45 | 75.11 | Upgrade
|
| Long-Term Debt Repaid | - | -145.76 | -146.7 | -178.33 | -130.52 | Upgrade
|
| Total Debt Repaid | -109.07 | -145.76 | -146.7 | -178.33 | -130.52 | Upgrade
|
| Net Debt Issued (Repaid) | -4.29 | -17.19 | 2.88 | 3.12 | -55.41 | Upgrade
|
| Issuance of Common Stock | - | 23.85 | - | 4.82 | - | Upgrade
|
| Repurchase of Common Stock | -1.94 | -1.27 | -0.15 | -0.27 | -0.79 | Upgrade
|
| Other Financing Activities | -1.37 | 1.04 | 4.78 | -6.05 | -0.82 | Upgrade
|
| Financing Cash Flow | -7.59 | 6.42 | 7.51 | 39.7 | -57.02 | Upgrade
|
| Net Cash Flow | 15.78 | -0.2 | -10.63 | 17.45 | 0.35 | Upgrade
|
| Free Cash Flow | 6.23 | -13.62 | -18.14 | -38.92 | -52.53 | Upgrade
|
| Free Cash Flow Margin | 4.81% | -10.57% | -14.14% | -37.69% | -47.21% | Upgrade
|
| Free Cash Flow Per Share | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 | Upgrade
|
| Cash Interest Paid | 2.52 | 1.91 | 2.73 | 31.02 | 16.89 | Upgrade
|
| Cash Income Tax Paid | -0.02 | 0.05 | 0.07 | 0.02 | 0.44 | Upgrade
|
| Levered Free Cash Flow | - | -29.04 | -20.27 | 16.29 | -26.82 | Upgrade
|
| Unlevered Free Cash Flow | - | -15.19 | -8.93 | 27.28 | -17.15 | Upgrade
|
| Change in Working Capital | -5.31 | -4.7 | -3.7 | 19.79 | -3.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.